These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31759945)

  • 1. An immunocompetent rat model of infection with Cryptosporidium hominis and Cryptosporidium parvum.
    Dayao DA; Sheoran A; Carvalho A; Xu H; Beamer G; Widmer G; Tzipori S
    Int J Parasitol; 2020 Jan; 50(1):19-22. PubMed ID: 31759945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Two Mouse Models for Vaccine Evaluation against Cryptosporidiosis.
    Dayao DA; Jaskiewcz J; Lee S; Oliveira BC; Sheoran A; Widmer G; Tzipori S
    Infect Immun; 2022 Jul; 90(7):e0012722. PubMed ID: 35735982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with anthroponotic Cryptosporidium parvum does not fully protect the host against a subsequent challenge with C. hominis.
    Sheoran AS; Pina-Mimbela R; Keleher A; Girouard D; Tzipori S
    Microbes Infect; 2018 Apr; 20(4):267-270. PubMed ID: 29357304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
    Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
    Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.
    Matsubayashi M; Teramoto-Kimata I; Uni S; Lillehoj HS; Matsuda H; Furuya M; Tani H; Sasai K
    J Biol Chem; 2013 Nov; 288(47):34111-34120. PubMed ID: 24085304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host immune response to Cryptosporidium parvum infection.
    Petry F; Jakobi V; Tessema TS
    Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptosporidium parvum biliary tract infection in adult immunocompetent and immunosuppressed mice.
    Verdon R; Polianski J; Grodet A; Garry L; Carbon C
    J Med Microbiol; 1998 Jan; 47(1):71-7. PubMed ID: 9449952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in cryptosporidiosis: the immune response.
    Riggs MW
    Microbes Infect; 2002 Aug; 4(10):1067-80. PubMed ID: 12191657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects.
    Shirafuji H; Xuan X; Kimata I; Takashima Y; Fukumoto S; Otsuka H; Nagasawa H; Suzuki H
    J Parasitol; 2005 Apr; 91(2):476-9. PubMed ID: 15986633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection.
    Liu K; Zai D; Zhang D; Wei Q; Han G; Gao H; Huang B
    Parasite Immunol; 2010 May; 32(5):335-44. PubMed ID: 20500662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice.
    Huang Y; Cao W; Shi K; Mi R; Lu K; Han X; Chen Z
    Parasite Immunol; 2017 Sep; 39(9):. PubMed ID: 28599077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.
    Sheoran A; Wiffin A; Widmer G; Singh P; Tzipori S
    J Infect Dis; 2012 Mar; 205(6):1019-23. PubMed ID: 22279124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Cryptosporidium Serologic Responses by Multiplex Bead Assay.
    Priest JW; Moss DM
    Methods Mol Biol; 2020; 2052():61-85. PubMed ID: 31452157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.
    Doyle PS; Crabb J; Petersen C
    Infect Immun; 1993 Oct; 61(10):4079-84. PubMed ID: 8406795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
    Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
    J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgG antibodies in sera from patients with Cryptosporidium parvum and Cryptosporidium hominis.
    Chalmers RM; Elwin K; Cheesbrough J; Hadfield SJ; Beeching NJ
    J Infect; 2013 Sep; 67(3):231-7. PubMed ID: 23644097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.
    Benitez A; Priest JW; Ehigiator HN; McNair N; Mead JR
    Vaccine; 2011 Nov; 29(49):9239-45. PubMed ID: 21968447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India.
    Ajjampur SS; Sarkar R; Allison G; Banda K; Kane A; Muliyil J; Naumova E; Ward H; Kang G
    Clin Vaccine Immunol; 2011 Apr; 18(4):633-9. PubMed ID: 21288997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of surface antigen-1 (SA-1) immune lymphocyte subsets and naive cell subsets in protecting scid mice from initial and persistent infection with Cryptosporidium parvum.
    Tatalick LM; Perryman LE
    Vet Immunol Immunopathol; 1995 Jul; 47(1-2):43-55. PubMed ID: 8533299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum.
    Ehigiator HN; Romagnoli P; Priest JW; Secor WE; Mead JR
    Parasitol Res; 2007 Sep; 101(4):943-50. PubMed ID: 17487508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.